Stock listing
Malin Corporation Plc
Selected listing: 0Y71 · LSE · EUR · GB
Malin Corporation Plc (LSE:0Y71), Health Technology. Latest release Feb 26, 2026: Malin Corporation Says CEO Fiona Dunlevy Will Leave Malin End Of May.
- Ticker
- LSE:0Y71
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- LSE
- Currency
- EUR
About Malin Corporation Plc
The company is focused on developing and commercializing innovative biotechnology solutions. Malin aims to advance healthcare through strategic partnerships and investments in the life sciences sector.
Latest news from Malin Corporation Plc
Malin Corporation Says CEO Fiona Dunlevy Will Leave Malin End Of May
February 26, 2026
REG - Malin Corp PLC - Block listing Interim Review
November 4, 2025
MLC: Intrinsic equity value was €41.3M on 30 June 2025, with €13.7M in cash
August 27, 2025
MLC: Major divestments drove a €150m capital return and record cash reserves for Malin in 2024
February 19, 2025
MLC: Cash surges to €62.9m post-CG Oncology sale; €45m capital return planned for shareholders
August 27, 2024
Research Malin Corporation Plc
Malin Corporation Plc company profile
View the public company page for Malin Corporation Plc on 6ix.
Malin Corporation Plc news
Read company news and market updates connected to Malin Corporation Plc.
Malin Corporation Plc investor events
Find investor webinars, events, and replay context for Malin Corporation Plc.
Alternate listings
MLC:EURONEXT
IE · EUR
Alternate listing for Malin Corporation Plc; the primary context on this page is 0Y71:LSE.
MLLNF:OTC
US · USD
Alternate listing for Malin Corporation Plc; the primary context on this page is 0Y71:LSE.
MLCI:TURQUOISE
GB · EUR
Alternate listing for Malin Corporation Plc; the primary context on this page is 0Y71:LSE.